BioSpace News Archive

Pharm Country

Global Telemonitoring Systems Market to Grow on Account of Rising Number of Patients with Physical Disabilities such as Paralysis

The global market for Telemonitoring systems has been reaping benefits from the development of better systems and procedures within the healthcare industry.

March 17, 2020
·
3 min read
Drug Development

Novo Nordisk Pauses Three Clinical Trials Because of Non-Fatal Thrombotic Events

No more patients will be enrolled in the trials and current treatment “will cease” while they determine the risks and plans for the trials.

March 17, 2020
·
3 min read
·
Mark Terry
Business

Pfizer and BioNTech to Develop mRNA Vaccine for COVID-19

The two companies will focus on BioNTech’s BNT162, an mRNA-based vaccine candidate.

March 17, 2020
·
3 min read
·
Alex Keown
IQVIA Report: Spending on Drugs Globally to Exceed $1.1 Trillion by 2024

Global medicine spending is projected to increase from 2 to 5% annually through 2024 on a net basis, compared to 4.2% in the past five years.

March 17, 2020
·
5 min read
·
Mark Terry
Business

Approximately 100 COVID-19 Cases Stem from Biogen Meeting

Approximately 100 cases of COVID-19 have been linked to a Biogen corporate meeting, as reported by a local media station in the Boston area.

March 17, 2020
·
2 min read
·
Alex Keown
Pharm Country

Incontinence Products Market: Rising Adoption of Personal Hygiene products in Developing Economies Benefits Global Market

Transparency Market Research presents a new market study on the global incontinence products market for the forecast period extending between 2016 and 2024.

March 17, 2020
·
3 min read
Drug Development

AstraZeneca’s Checkpoint Inhibitor Imfinzi Helps Overall Survival in Lung Cancer

“We are pleased to see the sustained and meaningful survival benefit of Imfinzi for patients with small cell lung cancer after more than two years median follow up,” said Jose Baselga, Astra Zeneca’s executive vice president, Oncology R&D.

March 17, 2020
·
2 min read
·
Mark Terry
Business

CureVac Chief Takes Non-Coronavirus Leave of Absence

There has been something of a furor over reports in the German newspaper Welt am Sonntag that claimed the Trump administration offered a “billion dollars” for exclusive rights to a coronavirus vaccine in development by German company CureVac, “but only for the USA.”

March 17, 2020
·
3 min read
·
Mark Terry
Drug Development

Findings Reveal Lack of Participants in Critical Research is Caused by Fear

Researchers found fear of testing new treatments and possible side effects were common denominators among patients.

March 17, 2020
·
2 min read
·
Michelle Brugioni
Biotech Bay

Biobanks Market: Increased Research on Genomics to Drive Demand

Intense competition and continuous upsurge in the business demands are mandating the market players to come up with new deliverables that are innovative and services at competitive rates, notes TMR Research in its newest report.

March 17, 2020
·
3 min read